Novo Nordisk

DESCRIPTION

Novo Nordisk is a global healthcare company specializing in diabetes, obesity, and rare endocrine disorders. Through its commitment to digital health and biotechnology, it integrates cutting-edge technology to enhance patient monitoring, treatment adherence, and overall healthcare efficiency

Key figures

+100 years of expertise in diabetes and endocrinology
+37 million patients using Novo Nordisk treatments worldwide
+120  countries with active operations and R&D investments

 

Related Projects

Showing the single result